28/08/2026
Omega-3s are often discussed as though they produce one broad “anti-inflammatory” effect. The biology is more specific than that.
The main long-chain omega-3 fatty acids, EPA and DHA, become part of the phospholipid membranes that surround cells throughout the body. DHA is especially concentrated in the brain and retina, where it contributes to membrane structure and function. ALA, the plant-derived omega-3 found in foods such as flax and walnuts, is essential too, but humans convert only small amounts of it into EPA and DHA.
The clearest clinical effect of EPA is on triglycerides. At prescription doses of about 4 g/day, omega-3 fatty acids typically lower elevated triglycerides by roughly 20–30%, with larger reductions possible when baseline triglycerides are very high. That is a pharmacologic dose and should not be confused with the amount in an ordinary fish-oil capsule or a serving of fish.
Blood pressure moves too, but much less dramatically. A dose-response meta-analysis of 71 randomized trials found that about 2–3 g/day of combined EPA and DHA reduced systolic pressure by roughly 2.6 mm Hg and diastolic pressure by about 1.6–1.8 mm Hg on average. The effect tended to be larger in people who already had hypertension or elevated blood lipids.
EPA and DHA also serve as raw material for signaling molecules involved in the regulation and resolution of inflammation. That does not mean taking fish oil simply “turns inflammation off.” The downstream response depends on dose, tissue, baseline status and the biological problem being studied.
This distinction matters because the strongest evidence for omega-3s is not equally strong across every claim attached to them. Their incorporation into cell membranes is established biology. DHA enrichment in brain and retinal tissue is well documented. Triglyceride lowering is a clear clinical effect, and blood-pressure lowering is modest but reproducible. Broader claims about cognition, mood, inflammation or cardiovascular protection depend much more heavily on the population, dose and specific EPA/DHA formulation being tested.
So omega-3s are better understood as structural and signaling fats with a few well-established measurable effects, rather than as a single-purpose supplement.
NIH Office of Dietary Supplements. Omega-3 Fatty Acids Fact Sheet.
PMID 31422671.
PMID 35647665.
